Project TEAM: Teaching HIV Prevention in the HIV Clinic

This study has been completed.
Sponsor:
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00164320
First received: September 9, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study is to determine if the TEAM prevention intervention delivered by a physician and an HIV-positive counselor is effective. It is hypothesized that those who receive the intervention will report a higher reduction in risky sex than those who were in the standard-care condition.


Condition Intervention Phase
HIV
Behavioral: TEAM
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Project TEAM: Teaching HIV Prevention in the HIV Clinic

Resource links provided by NLM:


Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Self-reported unprotected (without condoms)anal or vaginal sex with HIV-negative or unknown-status persons.

Estimated Enrollment: 600
Study Start Date: May 2004
Estimated Study Completion Date: May 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • 1) 18 years or older, 2) HIV-infected, 3) Sexually active, 3)Receiving HIV primary care at participating clinic, 4) Can communicate in English or Spanish, 5) No previous enrollment in the TEAM study or intervention.

Exclusion Criteria:

  • 1) Participation in a similar study run by the TEAM PI.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00164320

Locations
United States, Florida
University of Miami School of Medicine
Miami, Florida, United States, 33136
Sponsors and Collaborators
Investigators
Study Director: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
Principal Investigator: Lisa Metsch, PhD. University of Miami
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00164320     History of Changes
Other Study ID Numbers: CDC-NCHSTP-3699, R18/CCR420971-01
Study First Received: September 9, 2005
Last Updated: September 9, 2005
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on August 01, 2014